| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0383799B2 Adheson variants |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188427C Recombinant chimeric peptide antigen for detecting HCMV antibody and production method thereof |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852320 T cell inhibitory receptor compositions and uses thereof |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005010031A1 Peptides capable of binding to titanium, silver and silicone |
| 02/03/2005 | WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501861A1 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1432451A4 Production of fusion proteins and use for identifying binding molecules |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1572801A Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/01/2005 | US6849715 Agents useful for inactivation of Ras subfamily proteins |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/27/2005 | US20050020824 Testis-specific receptor |
| 01/27/2005 | US20050019869 Chimeric neuropeptide Y receptors |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019773 Method for producing and identifying soluble protein domains |
| 01/27/2005 | US20050019334 Interleukin antibody or fusion protein; comprising active material and FC domain; Escherichia coli cells |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1499885A2 Novel fusion proteins and assays for molecular binding |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499362A1 Fusions of cytokines and tumor targeting proteins |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499349A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499176A2 Novel vip3 toxins and methods of use |
| 01/26/2005 | EP0862637B1 Pseudomonas exotoxin - myelin basic protein chimeric proteins |
| 01/26/2005 | CN1570104A Infuse protein of candida albicans hot shock protein 90 epitope and phage envelop protein , and its uses |
| 01/26/2005 | CN1569900A Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE |
| 01/26/2005 | CN1569899A Recombinant nerve putrescence virus protein vaccine and its coding sequence and uses |
| 01/26/2005 | CN1186448C Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846905 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 01/25/2005 | CA2308292C Method of dna shuffling |
| 01/20/2005 | WO2004050698A3 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050015830 transforming or transfecting using nucleotide sequence encoding fusion protein, signal peptide and polypeptide to help in binding to cell wall; |
| 01/20/2005 | US20050014688 Inducer of apoptosis |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497649A2 Antibodies specific for mucin polypeptide |
| 01/19/2005 | EP1497634A2 Protein knobs |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497441A1 Synthetic transfer complex and method for transferring nucleic acids |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497333A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 01/19/2005 | EP1496927A2 Targeted immunogens |
| 01/19/2005 | EP1496926A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1463942A4 Methods for purifying protein |
| 01/19/2005 | CN1568369A Hybrid interferon/interferon Tau proteins, compositions and methods of use |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1566346A Expression and separation purification for S-protein of recombinant SARS coronavirus |
| 01/19/2005 | CN1566342A Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 01/19/2005 | CN1566159A Genet engineering recombinant protein capable of specifically killing tumor cell |
| 01/19/2005 | CN1566158A Recombinant vaccine for prevention and treatment of SARS virus |
| 01/19/2005 | CN1566157A Preparing method and use for osteoprotegerin fusion protein |
| 01/19/2005 | CN1566156A Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 01/19/2005 | CN1185261C Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/13/2005 | WO2005003356A1 ENDO-β-(1→6)-GALACTANASE |
| 01/13/2005 | WO2005003177A2 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 01/13/2005 | WO2005002512A2 Immunotherapeutic vaccine strategy |
| 01/13/2005 | WO2004077062A3 Method for selecting a candidate drug compound |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003072715A8 Gasp1: a follistatin domain containing protein |
| 01/13/2005 | US20050009167 Alkaline protease from Bacillus sp. (DSM 14390) and washing and cleaning products comprising said alkaline protease |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009145 Mammalian receptor proteins; related reagents and methods |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050006807 Obtaining protein mixture; incubating with crosslinking agent; molding; hardening; removal from mold |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2530393A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494697A1 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP0770088B1 Novel cytokine designated lerk-5 |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |